These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25724484)

  • 21. Replication of a rare protective allele in the noradrenaline transporter gene and ADHD.
    Xu X; Hawi Z; Brookes KJ; Anney R; Bellgrove M; Franke B; Barry E; Chen W; Kuntsi J; Banaschewski T; Buitelaar J; Ebstein R; Fitzgerald M; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant J; Sonuga-Barke E; Steinhausen HC; Faraone SV; Gill M; Asherson P
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1564-7. PubMed ID: 18937296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further evidence of association between two NET single-nucleotide polymorphisms with ADHD.
    Kim JW; Biederman J; McGrath CL; Doyle AE; Mick E; Fagerness J; Purcell S; Smoller JW; Sklar P; Faraone SV
    Mol Psychiatry; 2008 Jun; 13(6):624-30. PubMed ID: 17876324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing for the mediating role of endophenotypes using molecular genetic data in a twin study of ADHD traits.
    Pinto R; Asherson P; Ilott N; Cheung CH; Kuntsi J
    Am J Med Genet B Neuropsychiatr Genet; 2016 Oct; 171(7):982-92. PubMed ID: 27230021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional brain perfusion before and after treatment with methylphenidate may be associated with the G1287A polymorphism of the norepinephrine transporter gene in children with attention-deficit/hyperactivity disorder.
    Park MH; Kim JW; Yang YH; Hong SB; Park S; Kang H; Kim BN; Shin MS; Yoo HJ; Cho SC
    Neurosci Lett; 2012 Apr; 514(2):159-63. PubMed ID: 22405810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder.
    Kim CH; Hahn MK; Joung Y; Anderson SL; Steele AH; Mazei-Robinson MS; Gizer I; Teicher MH; Cohen BM; Robertson D; Waldman ID; Blakely RD; Kim KS
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19164-9. PubMed ID: 17146058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The possible involvement of genetic variants of NET1 in the etiology of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.
    Liu L; Cheng J; Li H; Yang L; Qian Q; Wang Y
    J Child Psychol Psychiatry; 2015 Jan; 56(1):58-66. PubMed ID: 24942521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample.
    Kim JW; Kim BN; Cho SC
    J Psychiatr Res; 2006 Dec; 40(8):730-7. PubMed ID: 16368111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No association of the norepinephrine transporter gene (SLC6A2) and cognitive and behavioural phenotypes of patients with autism spectrum disorder.
    Park S; Park JE; Cho SC; Kim BN; Shin MS; Kim JW; Cho IH; Kim SA; Park M; Park TW; Son JW; Chung US; Yoo HJ
    Eur Arch Psychiatry Clin Neurosci; 2014 Sep; 264(6):507-15. PubMed ID: 24381062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficiency of Sustained Attention in ADHD and Its Potential Genetic Contributor MAOA.
    Liu L; Cheng J; Su Y; Ji N; Gao Q; Li H; Yang L; Sun L; Qian Q; Wang Y
    J Atten Disord; 2018 Jul; 22(9):878-885. PubMed ID: 25784069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No evidence of linkage or association between the norepinephrine transporter (NET) gene MnlI polymorphism and adult ADHD.
    De Luca V; Muglia P; Jain U; Kennedy JL
    Am J Med Genet B Neuropsychiatr Genet; 2004 Jan; 124B(1):38-40. PubMed ID: 14681910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD.
    Bralten J; Franke B; Waldman I; Rommelse N; Hartman C; Asherson P; Banaschewski T; Ebstein RP; Gill M; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant JA; Oosterlaan J; Sonuga-Barke E; Steinhausen HC; Faraone SV; Buitelaar JK; Arias-Vásquez A
    J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1204-1212.e1. PubMed ID: 24157394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential perinatal risk factors in children with attention-deficit/hyperactivity disorder by subtype.
    Park S; Cho SC; Kim JW; Shin MS; Yoo HJ; Oh SM; Han DH; Cheong JH; Kim BN
    Psychiatry Res; 2014 Nov; 219(3):609-16. PubMed ID: 24997783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of dopamine D4 receptor (DRD4) gene with attention-deficit/hyperactivity disorder (ADHD) in a high-risk community sample: a longitudinal study from birth to 11 years of age.
    El-Faddagh M; Laucht M; Maras A; Vöhringer L; Schmidt MH
    J Neural Transm (Vienna); 2004 Jul; 111(7):883-9. PubMed ID: 15206004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A high density linkage disequilibrium mapping in 14 noradrenergic genes: evidence of association between SLC6A2, ADRA1B and ADHD.
    Hawi Z; Matthews N; Barry E; Kirley A; Wagner J; Wallace RH; Heussler HS; Vance A; Gill M; Bellgrove MA
    Psychopharmacology (Berl); 2013 Feb; 225(4):895-902. PubMed ID: 23052569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of norepinephrine transporter gene polymorphisms in attention-deficit/hyperactivity disorder in Korean population.
    Oh SY; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; ():. PubMed ID: 27984158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder.
    Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD
    Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association.
    Rippel CA; Kobets AJ; Yoon DY; Williams PN; Shugart YY; Bridges DD; Vandenbergh DJ; Singer HS
    Psychiatr Genet; 2006 Oct; 16(5):179-80. PubMed ID: 16969268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor).
    Johann M; Bobbe G; Putzhammer A; Wodarz N
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1527-34. PubMed ID: 14574222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The norepinephrine transporter gene modulates intrinsic brain activity, visual memory, and visual attention in children with attention-deficit/hyperactivity disorder.
    Shang CY; Lin HY; Gau SS
    Mol Psychiatry; 2021 Aug; 26(8):4026-4035. PubMed ID: 31595036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychological performance measures as intermediate phenotypes for attention-deficit/hyperactivity disorder: A multiple mediation analysis.
    Kamradt JM; Nigg JT; Friderici KH; Nikolas MA
    Dev Psychopathol; 2017 Feb; 29(1):259-272. PubMed ID: 27049476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.